Latham Advises on Private Credit Financing for Apex Infusion’s Partnership With SkyKnight Capital

Apex Infusion, a leading omnichannel infusion services provider, has entered into a definitive agreement to partner with SkyKnight Capital, L.P., a private equity firm with a track record of building industry-defining businesses alongside exceptional management teams, to drive the Company’s next chapter of growth. Apex's clinician-led management team will retain a significant ownership stake and continue to lead the business. FFL Partners will also remain a minority investor in the company. The partnership is subject to customary closing conditions, including the receipt of required regulatory approvals.

Latham & Watkins LLP represented the private credit funds supporting the transaction with a team led by Stelios Saffos, Global Chair of Latham’s Capital Markets and Hybrid Capital practices, Alfred Xue, Global Vice Chair of the Banking & Private Credit Practice, and partners Abhay Lele and Josh Holt, with associates Julio Martinez Rivas and Cynthia Yang. Advice was also provided on tax matters by partner Bora Bozkurt, with associate James Aldred.